| Accession |
PRJCA005206 |
| Title |
Dynamic recurreAgriculturalnce risk and adjuvant chemotherapy benefit prediction by Circulating tumor DNA in resected non-small cell lung cancer |
| Relevance |
Medical |
| Data types |
Targeted Locus (Loci)
Raw sequence reads
Genome sequencing
|
| Organisms |
Homo sapiens
|
| Description |
In this study, we sought to evaluate the utility of ultradeep targeted next-generation sequencing (NGS) on serial longitudinal ctDNA sampling post-surgery in resected NSCLC patients for MRD detection and ACT treatment decision-making, and dynamic risk prediction of recurrence during post-surgical and post-ACT disease surveillance. |
| Sample scope |
Multiisolate |
| Release date |
2021-05-20 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| No funding support
|
|
|
|
|
|
| Submitter |
GUO
WEI (guowei@cicams.ac.cn)
|
| Organization |
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College |
| Submission date |
2021-03-17 |
